Oncology of CNS Tumors

The new edition has been completely revised to reflect the continually evolving landscape of neuro-oncology and provide readers with a thorough update that will inform their clinical practice. Since the previous edition, molecular neuropathology has progressed considerably, leading to a new understa...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Tonn, Jörg-Christian (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Reardon, David A. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Rutka, James T. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Westphal, Manfred (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:3rd ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04568nam a2200529 4500
001 978-3-030-04152-6
003 DE-He213
005 20191028142330.0
007 cr nn 008mamaa
008 190531s2019 gw | s |||| 0|eng d
020 |a 9783030041526  |9 978-3-030-04152-6 
024 7 |a 10.1007/978-3-030-04152-6  |2 doi 
040 |d GrThAP 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Oncology of CNS Tumors  |h [electronic resource] /  |c edited by Jörg-Christian Tonn, David A. Reardon, James T. Rutka, Manfred Westphal. 
250 |a 3rd ed. 2019. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2019. 
300 |a X, 794 p. 276 illus., 113 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Part 1: Patholgoy and Classification of tumors of the nervous system -- Ethiologica and epidemiological aspects -- Imaging -- Tumor biology -- Concepts of personalized medicine in neurooncology -- Local therapies -- Part 2: Tumors of the skull -- Meningeomas and meningeal tumors -- Astrocytoma and Oligodendroglioma -- Glioblastoma -- Ependymoma and ventricular tumors -- Medulloblastoma -- Pituitary Adenomas -- Tumors of the pineal region -- Tumors of the cranial nerves -- Hemangioblastoma and von Hippel Lindau disease -- tumors of the skull base -- Orbital tumors -- Primary CNS Lymphoma -- Brain metastases and meningeomatosis -- Part 3: Neurocutaneous syndromes -- Brainstem Gliomas -- Supratentorial lobar gliomas. Thalamic gliomas -- Optic pathway gliomas -- Ganglioglioma -- Cerebellar Astrocytoma -- Rare Childhood tumors -- Ependymoma -- Medulloblastoma -- Dysembryoplastic neuroepithelial tumor -- Craniopharyngioma -- Germ cell tumors -- Choroid plexus tumours -- ATRT -- Part 4: Intramedullary tumors -- Intradural extramedullary tumors -- Epidural tumors and metastatses -- Spinal radiosurgery -- Part 5: Peripheral nerve tumors -- Part 6: Aspects of general care in neurooncology -- Epilepsy and anticonvulsant therapy -- Hydrocephalus -- Pregnancy and birth control -- Late treatment sequelae -- Quality of life -- Palliativ Care. . 
520 |a The new edition has been completely revised to reflect the continually evolving landscape of neuro-oncology and provide readers with a thorough update that will inform their clinical practice. Since the previous edition, molecular neuropathology has progressed considerably, leading to a new understanding of specific clinical entities with corresponding changes in classification and treatment concepts. Moreover, tumor biology has become better integrated with clinical neuro-oncology in truly translational efforts. These advances receive detailed attention. In addition, the structure of the book has been adapted to align with the revised 2016 version of the WHO Brain Tumor Classification. Once again, the contributors have been carefully selected as leading experts in the field. Oncology of CNS Tumors is already established as a widely used reference, and this new edition will provide optimal value for highly specialized comprehensive neuro-oncology centers as well as practicing clinicians and researchers. 
650 0 |a Oncology  . 
650 0 |a Neurosurgery. 
650 0 |a Radiotherapy. 
650 0 |a Neurology . 
650 1 4 |a Oncology.  |0 http://scigraph.springernature.com/things/product-market-codes/H33160 
650 2 4 |a Neurosurgery.  |0 http://scigraph.springernature.com/things/product-market-codes/H39000 
650 2 4 |a Radiotherapy.  |0 http://scigraph.springernature.com/things/product-market-codes/H29056 
650 2 4 |a Neurology.  |0 http://scigraph.springernature.com/things/product-market-codes/H36001 
700 1 |a Tonn, Jörg-Christian.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Reardon, David A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Rutka, James T.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Westphal, Manfred.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783030041519 
776 0 8 |i Printed edition:  |z 9783030041533 
856 4 0 |u https://doi.org/10.1007/978-3-030-04152-6  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)